Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HLX07, HLX10, and Chemotherapy in ES-SCLC
NCT05354700Phase 2Unknown
- Sponsor
- Henlius
- Start
- Mar 2023
- Primary completion
- Mar 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of pimurutamab in small cell lung cancer (SCLC), sponsored by Henlius. Status: unknown.
02
Drugs
pimurutamab
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT05354700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05354700.